{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T19:01:50Z","timestamp":1780340510013,"version":"3.54.1"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.bcmd.2026.103010","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T23:22:38Z","timestamp":1779232958000},"page":"103010","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical and molecular characterization of Hb Coimbra [HBB: c.300T>A p.(Asp100Glu)] in a three-generation Italian family: From diagnostic pitfalls to vascular risk"],"prefix":"10.1016","volume":"119","author":[{"given":"Francesco","family":"Pezzoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Chiocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Tondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Fotzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.bcmd.2026.103010_bb0005","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1081\/HEM-58571","article-title":"Hemoglobins with high oxygen affinity leading to erythrocytosis. New variants and new concepts","volume":"29","author":"Wajcman","year":"2005","journal-title":"Hemoglobin"},{"issue":"2","key":"10.1016\/j.bcmd.2026.103010_bb0010","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.revmed.2016.06.003","article-title":"High oxygen affinity hemoglobins","volume":"38","author":"Mangin","year":"2017","journal-title":"Rev. Med. Interne"},{"issue":"6","key":"10.1016\/j.bcmd.2026.103010_bb0015","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3109\/03630269109027896","article-title":"Hb Coimbra or alpha 2 beta (2)99(G1)Asp----Glu, a newly discovered high oxygen affinity variant","volume":"15","author":"Tamagnini","year":"1991","journal-title":"Hemoglobin"},{"issue":"1","key":"10.1016\/j.bcmd.2026.103010_bb0020","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/03630269.2020.1720711","article-title":"Novel high oxygen affinity hemoglobin variant in a patient with polycythemia: Hb Kennisis [beta85(F1)Phe->Leu (TTT>TTG); HBB: c.258T>G]","volume":"44","author":"Al Nabhani","year":"2020","journal-title":"Hemoglobin"},{"issue":"9","key":"10.1016\/j.bcmd.2026.103010_bb0025","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3324\/haematol.2009.008037","article-title":"Identification of high oxygen affinity hemoglobin variants in the investigation of patients with erythrocytosis","volume":"94","author":"Percy","year":"2009","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.bcmd.2026.103010_bb0030","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1081\/HEM-100104026","article-title":"Abnormal hemoglobins: laboratory methods","volume":"25","author":"Wajcman","year":"2001","journal-title":"Hemoglobin"},{"key":"10.1016\/j.bcmd.2026.103010_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2019.102353","article-title":"High erythropoietin may be associated with vascular complications in patients with secondary erythrocytosis caused by high oxygen affinity variant hemoglobin Coimbra","volume":"79","author":"Santos","year":"2019","journal-title":"Blood Cells Mol. Dis."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979626000331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979626000331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:07:23Z","timestamp":1780337243000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979626000331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":7,"alternative-id":["S1079979626000331"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2026.103010","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and molecular characterization of Hb Coimbra [HBB: c.300T>A p.(Asp100Glu)] in a three-generation Italian family: From diagnostic pitfalls to vascular risk","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2026.103010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103010"}}